ARDELYX, INC. Quarterly Current Ratio in % from Q1 2015 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Ardelyx, Inc. quarterly Current Ratio history and growth rate from Q1 2015 to Q3 2024.
  • Ardelyx, Inc. Current Ratio for the quarter ending September 30, 2024 was 438 %, a 41.4% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 438 +128 +41.4% Sep 30, 2024
Q2 2024 473 +224 +90.1% Jun 30, 2024
Q1 2024 427 +185 +76.5% Mar 31, 2024
Q4 2023 373 +139 +59.3% Dec 31, 2023
Q3 2023 310 +70.2 +29.3% Sep 30, 2023
Q2 2023 249 +12.5 +5.27% Jun 30, 2023
Q1 2023 242 -16.8 -6.5% Mar 31, 2023
Q4 2022 234 -72.6 -23.6% Dec 31, 2022
Q3 2022 239 -137 -36.4% Sep 30, 2022
Q2 2022 236 -304 -56.2% Jun 30, 2022
Q1 2022 259 -410 -61.3% Mar 31, 2022
Q4 2021 307 -505 -62.2% Dec 31, 2021
Q3 2021 376 -549 -59.3% Sep 30, 2021
Q2 2021 540 -288 -34.8% Jun 30, 2021
Q1 2021 669 -233 -25.9% Mar 31, 2021
Q4 2020 812 -24 -2.87% Dec 31, 2020
Q3 2020 925 +141 +18% Sep 30, 2020
Q2 2020 828 -105 -11.2% Jun 30, 2020
Q1 2020 902 -176 -16.3% Mar 31, 2020
Q4 2019 836 -345 -29.2% Dec 31, 2019
Q3 2019 784 -352 -31% Sep 30, 2019
Q2 2019 933 -93.6 -9.12% Jun 30, 2019
Q1 2019 1.08K +199 +22.7% Mar 31, 2019
Q4 2018 1.18K +318 +36.8% Dec 31, 2018
Q3 2018 1.14K +213 +23.1% Sep 30, 2018
Q2 2018 1.03K -6.51 -0.63% Jun 30, 2018
Q1 2018 879 -213 -19.5% Mar 31, 2018
Q4 2017 863 -343 -28.5% Dec 31, 2017
Q3 2017 922 -374 -28.9% Sep 30, 2017
Q2 2017 1.03K -187 -15.4% Jun 30, 2017
Q1 2017 1.09K -383 -26% Mar 31, 2017
Q4 2016 1.21K +133 +12.4% Dec 31, 2016
Q3 2016 1.3K +473 +57.5% Sep 30, 2016
Q2 2016 1.22K +508 +71.2% Jun 30, 2016
Q1 2016 1.48K +963 +188% Mar 31, 2016
Q4 2015 1.07K Dec 31, 2015
Q3 2015 823 Sep 30, 2015
Q2 2015 713 Jun 30, 2015
Q1 2015 512 Mar 31, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.